| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95b3f78aa25ec90f442e9485b907ba97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate |
2015-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3557a509cd58aa4dc3b5542efaf1cc16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec0e8a0e78cbda4e23a2597a5b5d9d78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_275dc376dba13e4510bb08519b177aa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c861351f5a6231802aa1b648f57751e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac9428e3857248687de5879e5ce67e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee6cd5c735095124323efc8eafb2a56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af0b3dec5d08b9b81c5183995c0c8b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e73cbaf282a1d9e8e124703737d2623 |
| publicationDate |
2016-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9518086-B2 |
| titleOfInvention |
Crystalline and amorphous forms of a β-arrestin effector |
| abstract |
The present disclosure provides novel crystalline forms of a compound that acts as a β-arrestin effector, processes for preparing novel crystalline and amorphous forms of a compound that acts as a β-arrestin effector and uses thereof. |
| priorityDate |
2014-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |